⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29622282 | 1.00 | — | — | |
| Formaldehyde SCHEMBL28292213 | 0.93 | SMN1; SMN2 (0.45) | — | |
| SCHEMBL517158 | 0.89 | LMNA (0.42) | — | |
| Formic Acid SCHEMBL27951317 | 0.87 | TRIM24 (0.47) | — | |
| SCHEMBL29132983 | 0.82 | TRIM24 (0.43) | — | |
| SCHEMBL29666462 | 0.72 | CDC25B (0.46) | — | |
| SCHEMBL29361780 | 0.72 | — | — | |
| SCHEMBL29580420 | 0.72 | — | — | |
| SCHEMBL27892006 | 0.72 | LMNA (0.48) | — | |
| SCHEMBL212732 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390645-A | Dehalogenation method for reducing N heteroaryl halide by using hydrosilane | 浙江科技大学 | 2025-02-07 | — | — | CN | claimed |
| CN-114426516-B | Preparation method of 2-amino-3-bromopyridine | 安徽有吉医药科技有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-114426516-A | Preparation method of 2-amino-3-bromopyridine | 安徽有吉医药科技有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-110041252-A | A kind of preparation method of the chloro- 4- hydrazino pyridine of 2- | 南京合巨药业有限公司 | 2019-07-23 | — | — | CN | claimed |
| CN-105524008-B | The preparation method of oxazolidone antibacterial drug intermediate | 山东轩竹医药科技有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-107177588-A | Modified glass bead carrier for fixing Azodrin degradation bacteria and preparation method thereof | 光合强化（北京）生物科技有限公司 | 2017-09-19 | — | — | CN | claimed |
| CN-106701733-A | Modified zeolite functional material for fixing benzene degrading bacteria and preparation method thereof | 光合强化（北京）生物科技有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-105753780-A | A synthetic method of a medicine raw material 5-bromo-2-chloroisonicotinic acid | 无锡乾浩生物医药有限公司 | 2016-07-13 | — | — | CN | claimed |
| CN-105524008-A | Preparation method of oxazolidinone antimicrobial drug intermediate | KBP BIOSCIENCES CO LTD | 2016-04-27 | — | — | CN | claimed |
| CN-102970867-A | Aryl and heteroaryl sulfonamides as active agents against abiotic plant stress | BAYER IP GMBH | 2013-03-13 | — | — | CN | claimed |
| CN-101230036-A | Method for preparing heterocyclic aryl-aryl biphenyl compounds | UNIV ZHEJIANG (CN) | 2008-07-30 | — | — | CN | claimed |
| CN-1635877-A | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance | NEUROSEARCH AS (DK) | 2005-07-06 | — | — | CN | claimed |
| EP-3728239-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132143-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | AMGEN INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4739307-A2 | TARGETED EPIGENETIC THERAPIES FOR DISORDERS OF PROGRANULIN DEFICIENCY | The General Hospital Corporation (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739682-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| EP-0032516-B1 | NEW 2-HALO-PYRIDINES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS | LACER, S.A. (ES) | 1984-05-02 | — | — | EP | disclosed |
| EP-0065757-A1 | 1-(3-Halo-2-pyridinyl)piperazines, processes for their preparation and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1982-12-01 | — | — | EP | disclosed |
| EP-0032516-A1 | New 2-halo-pyridines, their production and pharmaceutical compositions | LACER, S.A. (ES) | 1981-07-29 | — | — | EP | disclosed |
| US-4052508-A | TRANQUILIZER, MUSCLE RELAXANT, ANTICONVULSANT, ANTIPARKINSON | MERCK & CO., INC. (US) | 1977-10-04 | — | — | US | disclosed |